CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 23 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,242 | -58.0% | 9,150 | -30.2% | 0.00% | – |
| Q2 2023 | $7,712 | +3.3% | 13,100 | 0.0% | 0.00% | – |
| Q1 2023 | $7,468 | +6.7% | 13,100 | +18.0% | 0.00% | – |
| Q4 2022 | $7,000 | -56.2% | 11,100 | 0.0% | 0.00% | – |
| Q3 2022 | $16,000 | +100.0% | 11,100 | +455.0% | 0.00% | – |
| Q4 2021 | $8,000 | -27.3% | 2,000 | 0.0% | 0.00% | – |
| Q3 2021 | $11,000 | -8.3% | 2,000 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $365,000 | 0.05% |
| McIlrath & Eck, LLC | 26,342 | $38,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 615,200 | $898,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 367,477 | $535,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,800 | $19,000 | 0.00% |
| Point72 Asset Management, L.P. | 230,000 | $336,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,816 | $90,000 | 0.00% |
| STATE STREET CORP | 10,510 | $15,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 195,445 | $285,000 | 0.00% |
| MORGAN STANLEY | 1,200 | $2,000 | 0.00% |